Lipids in Pulmonary Drug Delivery

Lipid Nanotechnology
Current Scenario and Challenges of Lipid-Based Nanomedicines for Pulmonary Drug Delivery
Effect of Environment of the Respiratory Tract on Nanomedicine Drug Delivery
Aerodynamics and Deposition of Lipid-Based Nanocarriers in Lungs
Liposome as a Versatile Carrier for Pulmonary Drug Delivery
Advancements in Nano-Structured Lipid Carrier (NLCs) as Drug Delivery Vehicle in Lungs
Solid Lipid Nanoparticles: A Potential Drug Carrier in Pulmonary System
Insights and Applications of Nanoemulsions as a Drug Carrier in Lungs
Lipid-Based Drug Delivery for Lung Cancer
Exploring the State-of-Art of Lipid Nanomedicines for Obstructive Pulmonary Diseases
Lipid-Based Drug Delivery for Pulmonary Microbial Infections
Lipid-Based Drug Delivery for Systemic Effect Through Pulmonary Route of Administration
Biofate of Lipid-Based Nanomedicine After Pulmonary Administration
Surface Modification of Lipid-Based Drug Delivery for Lungs
Evaluation of Lipid-Based Formulation for Pulmonary Delivery
Physico-Chemical Stability of Lipid-Based Nanocarriers in Aerosol Formulation
Translation of Lipid-Based Formulation for Pulmonary Drug Delivery System: Clinical Status
Regulatory Aspects of Lipid-Based Nanomedicine for Pulmonary Applications
Lipid-Based Vaccines Against Viruses Including COVID-19
Lipid-Based Nanocarriers in the Management of Cystic Fibrosis: A Pulmonary Complication
Pulmonary Drug Delivery of Lipid-Based Formulations via Nebulizers
Lipid-Based Peptide and Gene Delivery to Lungs

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Farmacologia
• Indústria farmacêutica

<P>Particle size; polydispersity index; alveoli; phospholipids; surfactants; epithelium; mucociliary clearance; goblet cells; airway</P>